Lifeward (LFWD) Q1 2025 Earnings Call May 15, 2025 08:30 AM ET Speaker0 Good day, and welcome to the Q1 twenty twenty five LifeForward, Inc. Earnings Conference Call. All participants will be in listen only mode. Please note this event is being recorded. I would now like to turn the conference over to Mike Lawless, Chief Financial Officer. Please go ahead. Speaker1 Thank you, Cindy. Good morning and welcome to LifeWorks first quarter twenty twenty five earnings call. I'm Mike Laulis, LifeWorks Chief Financi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36612 Lifeward Ltd. (Exact name of registrant as specified in charter) | Israel | | --- | | Not applicable | (State or other jurisdiction ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its first quarter 2025 financial results before the markets open on Thursday, May 15, 2025. Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference cal ...

Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to cover device arrives shortly after the launch of the ReWalk 7 Personal Exoskeleton, which was released for sales in the U.S. earlier this month MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global lead ...

Lifeward Ltd. (LFWD) recently launched the ReWalk 7 Personal Exoskeleton in the U.S. market, marking another milestone in assistive technology for individuals with spinal cord injuries. This seventh-generation device builds on Lifeward’s extensive experience and industry leadership, featuring a host of new technological advancements that enhance user independence and functionality.The ReWalk 7, which received FDA clearance in March 2025, follows earlier innovations introduced with the ReWalk 6.0 system, whi ...

Smarter, smoother, more powerful. Learn more at golifeward.com/rewalk7 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury New and improved features streamline user experience for greater control, engagement, and confidence during walking in everyday environments Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in inn ...

Lifeward Ltd. (LFWD) recently announced that it has received FDA 510(k) clearance for its latest innovation, the ReWalk 7 Exoskeleton. This next-generation wearable device is designed to help individuals with spinal cord injuries (SCI) stand and walk, featuring new and enhanced functionalities aimed at improving user experience and mobility outcomes.The FDA clearance marks a significant milestone for Lifeward, reinforcing its leadership in the medical exoskeleton market. With prior regulatory and reimbursem ...

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord InjuryMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that the Company has received 510(k) FDA clearance for the newest generation of its personal exoskeleton ...

Lifeward (LFWD) Q4 2024 Earnings Call March 07, 2025 04:52 PM ET Company Participants Mike Lawless - CFOLarry Jasinski - CEOBen Haynor - Managing Director Conference Call Participants Yale Jen - Senior Managing Director & Senior Biotech AnalystRamakanth Swayampakula - Managing Director & Senior Research Analyst Operator Good day, and welcome to the Life Learning Fourth Quarter twenty twenty four Earnings Conference Call. All participants will be in listen only mode. After today's presentation, there will be ...

Lifeward Ltd. (NASDAQ:LFWD) Q4 2024 Earnings Conference Call March 7, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw & Company Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C. Wainwright Operator Good day, and welcome to the Lifeward Inc. Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen only mode [Operator Instructions]. Please note, today's event is be ...